Ferring Pharmaceuticals Pty Ltd have advised HPS Pharmacies that manufacture of DURATOCIN (carbetocin) 100micrograms/1mL ampoules, Aust R 101230 has been temporarily halted during an investigation into quality control concerns.
Carbetocin is a long-acting synthetic analogue of oxytocin, and is used for the prevention of uterine atony and excessive bleeding following elective caesarean section.
During the expected shortage, medical practitioners may apply for a Special Access Scheme release of a Korean presentation of carbetocin, or prescribe oxytocin. HPS Pharmacies are happy to assist in accessing these products as required.
This is not a recall notice and all stocks available in Australia are safe to use.
Please retain this notice in a prominent position, including other related business units, until supplies return to normal. Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Ferring Pharmaceuticals on 1800 337 746.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.